Updated Practice Guideline: IPF and Progressive Pulmonary Fibrosis
A recent update of IPF clinical practice guideline addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Restrictive Lung Disease
RESTRICTIVE LUNG DISEASE
FEATURED
Using Electronic Health Records to Predict Mortality Post COPD Hospitalization
For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?
LATEST FEATURES
ATS Guideline: Outpatient Management of Pediatric Post-Prematurity Respiratory Disease
How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.
Pulmonologists vs Rheumatologists: Treating Rheumatoid Arthritis-Associated Interstitial Lung Disease
Rheumatologists and pulmonologists provide differing perspectives on risk factors, disease assessment, and treatment strategies for patients with rheumatoid arthritis-associated interstitial lung disease.
Diagnosing Hypersensitivity Pneumonitis: A New Clinical Practice Guideline
A multidisciplinary committee of international experts have released a new clinical practice guideline on the diagnosis of adult hypersensitivity pneumonitis, an immune-mediated inflammatory lung and small airway disease.
Risk Score Developed for RA-Linked Interstitial Lung Disease
A score has been developed to stratify the risk for subclinical rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Pulmonary Ultrasonography Detects Interstitial Lung Disease in Rheumatoid Arthritis
Researchers investigated the potential role in ultrasonography in the detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).
Effect of Interstitial Lung Disease Subtypes on COVID-19 Mortality
How does the COVID-19 mortality rate vary among patients with different subtypes of interstitial lung disease?
LATEST NEWS
Mechanical Forces in IPF and Lung Cancer: A New Therapeutic Target?
How does IPF increase risk for lung cancer morbidity/mortality? Researchers analyzed the potential mechanisms for this, which may represent new therapeutic targets.
Antifibrotic Pirfenidone in Patients With Progressive Pulmonary Fibrosis
Is the antifibrotic pirfenidone an effective and safe therapy for individuals with progressive pulmonary fibrosis?
Factors Linked to Poor Prognosis of RA-Associated Interstitial Lung Disease Determined
Researchers assessed the effect of clinical characteristics and treatment options on the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease.
Benefits of Vitamin Supplementation in Idiopathic Pulmonary Fibrosis
In patients with idiopathic pulmonary fibrosis, can supplementation with vitamins C, D, and E affect respiration, inflammation, and oxidative stress?
Cystic Fibrosis: Helping Teens, Young Adults Transition Into Making Care Decisions
How do adolescents and young adults with cystic fibrosis handle the transition to taking on their own treatment decisions, and what can be done to prepare for this transition?
Identifying Lung Impairment in Preschoolers With Primary Ciliary Dyskinesia
Can the Lung Clearance Index, which uses the multiple breath washout test, be used in preschool children to detect lung impairment from primary ciliary dyskinesia?
Dyspnea in Obesity Linked to Reduction in Lung Volumes, Higher BMIs
In patients with obesity, what relationships exist between dyspnea in daily living, lung function, and body composition?
Inhaled Therapy Gets Breakthrough Designation for Non-Cystic Fibrosis Bronchiectasis
The designation was supported by data from the multicenter, double-blind, placebo-controlled phase 3 PROMIS-I study.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Restrictive Lung Disease
Loading... 
Loading...